Pembrolizumab Plus mFOLFOX7 or FOLFIRI for Microsatellite-Stable/Mismatch Repair–Proficient Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Colorectal Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pembrolizumab Plus mFOLFOX7 or FOLFIRI for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer: KEYNOTE-651 Cohorts B and D
Clin Colorectal Cancer 2024 Jun 01;23(2)118-127.e6, R Kim, M Tehfe, P Kavan, J Chaves, JS Kortmansky, EX Chen, CH Lieu, L Wong, M Fakih, K Spencer, Q Zhao, R Predoiu, C Li, P Leconte, D Adelberg, EG ChioreanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.